CompletedPHASE1, PHASE2NCT04595513

Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Darcy Krueger, MD, PhD
Children's Hospital Medical Center, Cincinnati
Intervention
TAVT-18 (sirolimus)(drug)
Enrollment
5 enrolled
Eligibility
All sexes
Timeline
20202022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04595513 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome

← Back to all trials